Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets
Molecules · 20.03.2024 · 29 (6) · 1373
DOI: 10.3390/molecules29061373 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 20.03.2024. Verfasst von Wamidh H Talib und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Allied Medical Sciences, Applied Science Private University, Amman 11931, Jordan. Hauptthemen laut MEDLINE: Catechin, Neoplasms. Die Arbeit wurde bisher 117-mal zitiert (Crossref) und nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Applied Science Private University, Amman, Jordan.
Abstract (Originalsprache)
Epigallocatechin gallate (EGCG) is a catechin, which is a type of flavonoid found in high concentrations in green tea. EGCG has been studied extensively for its potential health benefits, particularly in cancer. EGCG has been found to exhibit anti-proliferative, anti-angiogenic, and pro-apoptotic effects in numerous cancer cell lines and animal models. EGCG has demonstrated the ability to interrupt various signaling pathways associated with cellular proliferation and division in different cancer types. EGCG anticancer activity is mediated by interfering with various cancer hallmarks. This article summarize and highlight the effects of EGCG on cancer hallmarks and focused on the impacts of EGCG on these cancer-related hallmarks. The studies discussed in this review enrich the understanding of EGCG’s potential as a therapeutic tool against cancer, offering a substantial foundation for scientists and medical experts to advance scientific and clinical investigations regarding EGCG’s possibility as a potential anticancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Allied Medical Sciences, Applied Science Private University, Amman 11931, Jordan.
- Department of Clinical Pharmacy and Therapeutics, Applied Science Private University, Amman 11931, Jordan.
- Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa 13133, Jordan.
- Department of Health Sciences, College of Natural and Health Sciences, Zayed University, Abu Dhabi 144534, United Arab Emirates.
ORCID-Profile: Wamidh H Talib, Dima Awajan, Abdelrahim Alqudah, Raha Althunibat, Mahmoud Abu AlRoos, Lina T Al Kury
Förderung
- Applied Science Private University, Amman, Jordan
Zitieren
APA
Talib, W. H., Awajan, D., Alqudah, A., Alsawwaf, R., Althunibat, R., Abu AlRoos, M., Al Safadi, A., Abu Asab, S., Hadi, R. W., & Al Kury, L. T. (2024). Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets. Molecules, 29(6), 1373. https://doi.org/10.3390/molecules29061373
Vancouver
Talib WH, Awajan D, Alqudah A, Alsawwaf R, Althunibat R, Abu AlRoos M, et al. Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets. Molecules. 2024;29(6):1373. doi:10.3390/molecules29061373
BibTeX
@article{Talib2024,
author = {Talib, Wamidh H and Awajan, Dima and Alqudah, Abdelrahim and Alsawwaf, Razan and Althunibat, Raha and Abu AlRoos, Mahmoud and Al Safadi, Ala'a and Abu Asab, Sharif and Hadi, Rawan W and Al Kury, Lina T},
title = {Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets},
journal = {Molecules},
year = {2024},
volume = {29},
number = {6},
pages = {1373},
doi = {10.3390/molecules29061373}
}
EUVIMED